Freestone Capital Holdings, LLC Biogen Inc. Transaction History

Freestone Capital Holdings, LLC

$2.9 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $194,291 - $231,048	-1,036 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $2,131 - $2,685	11 Added 1.07%	1,036 $218,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $28,213 - $36,259	126 Added 14.02%	1,025 $246,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $6,791 - $8,857	-24 Reduced 2.6%	899 $254,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $33,152 - $53,082	-128 Reduced 12.18%	923 $320,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $14,091 - $16,508	58 Added 5.84%	1,051 $294,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $43,708 - $65,791	-185 Reduced 15.7%	993 $243 Million
Q3 2020 Nov 06, 2020	SELL	$264.77 - $305.71 $47,129 - $54,416	-178 Reduced 13.13%	1,178 $334,000
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $55,094 - $72,963	-213 Reduced 13.58%	1,356 $363,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $333,374 - $422,889	-1,240 Reduced 44.14%	1,569 $496,000
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $370,801 - $512,357	-1,685 Reduced 37.49%	2,809 $834,000
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $288,325 - $323,384	-1,326 Reduced 22.78%	4,494 $1.05 Million
Q2 2019 Aug 05, 2019	SELL	$219.29 - $241.72 $6.63 Million - $7.31 Million	-30,245 Reduced 83.86%	5,820 $1.36 Million
Q1 2019 May 08, 2019	BUY	$216.71 - $338.96 $296,242 - $463,358	1,367 Added 3.94%	36,065 $8.53 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $4.25 Million - $5.39 Million	-15,269 Reduced 30.56%	34,698 $10.4 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $11.9 Million - $15.6 Million	40,645 Added 436.01%	49,967 $17.7 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $2.4 Million - $2.86 Million	9,322 New	9,322 $2.71 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Account